Blood, antisera, vaccines, toxins and cultures in Germany 2019 Exports | Imports : $29.8B | $21.1B, World Rnk 3 / 201 Rnk 5 / 1216 | World Rnk 2 / 222 Rnk 6 / 1215
2018 - 2019 FASTEST GROWING MARKET | FASTEST GROWING ORIGIN: $1.03B | $751M, United States | United States
2019 ECONOMIC COMPLEXITY of Germany: 1.93, Rnk 4 / 147
2019 PRODUCT COMPLEXITY IN Blood, antisera, vaccines, toxins and cultures: 1.19, Rnk 110 / 1029
Exports In 2019, Germany exported $29.8B in Blood, antisera, vaccines, toxins and cultures, making it the 3rd largest exporter of Blood, antisera, vaccines, toxins and cultures in the world. At the same year, Blood, antisera, vaccines, toxins and cultures was the 5th most exported product in Germany. The main destination of Blood, antisera, vaccines, toxins and cultures exports from Germany are: Netherlands ($4.65B), United States ($4.34B), Switzerland ($2.63B), Italy ($2.23B), and China ($1.61B).
The fastest growing export markets for Blood, antisera, vaccines, toxins and cultures of Germany between 2018 and 2019 were United States ($1.03B), China ($613M), and Switzerland ($169M).
Imports In 2019, Germany imported $21.1B in Blood, antisera, vaccines, toxins and cultures, becoming the 2nd largest importer of Blood, antisera, vaccines, toxins and cultures in the world. At the same year, Blood, antisera, vaccines, toxins and cultures was the 6th most imported product in Germany. Germany imports Blood, antisera, vaccines, toxins and cultures primarily from: Switzerland ($4.76B), United States ($3.58B), Belgium ($2.3B), Netherlands ($2.02B), and Ireland ($1.11B).
The fastest growing import markets in Blood, antisera, vaccines, toxins and cultures for Germany between 2018 and 2019 were United States ($751M), Switzerland ($577M), and Australia ($346M).
EXPORTS (2019): $29.8B
IMPORTS (2019): $21.1B
NET TRADE (2019): $8.73B
In 2019, Germany exported $29.8B in Blood, antisera, vaccines, toxins and cultures. The main destinations of Germany exports on Blood, antisera, vaccines, toxins and cultures were Netherlands ($4.65B), United States ($4.34B), Switzerland ($2.63B), Italy ($2.23B), and China ($1.61B).
In 2019, Germany imported $21.1B in Blood, antisera, vaccines, toxins and cultures, mainly from Switzerland ($4.76B), United States ($3.58B), Belgium ($2.3B), Netherlands ($2.02B), and Ireland ($1.11B).
IN 2019, Germany HAD A POSITIVE NET TRADE IN Blood, antisera, vaccines, toxins and cultures WITH:
IN 2019, Germany HAD A NEGATIVE NET TRADE IN Blood, antisera, vaccines, toxins and cultures WITH:
THE FASTEST GROWING Blood, antisera, vaccines, toxins and cultures EXPORT MARKETS FOR Germany WERE (2018 - 2019):
THE FASTEST DECLINING MARKETS FOR THE EXPORT OF Blood, antisera, vaccines, toxins and cultures BY Germany WERE (2018 - 2019):
In 2019, Germany's main exporting competitors in Blood, antisera, vaccines, toxins and cultures were:
In 2019, Germany's main importing competitors in Blood, antisera, vaccines, toxins and cultures were:
In 2017, the tariffs for Blood, antisera, vaccines, toxins and cultures in the imports of Germany were of 0% around the world.